lung cancer | |||||
新闻 | |||||
Cell Therapy for Non-Small Cell Lung Cancer by Shanghai Biomed-Union Biotechnology for ... According to GlobalData, Phase I drugs for Non-Small Cell Lung Cancer have an 80% phase transition success rate (PTSR) indication benchmark for ...
| |||||
AUR-109 by Orion for Lung Cancer: Likelihood of Approval - Pharmaceutical Technology AUR-109 is under development for the treatment of urothelial transitional cell carcinoma, advanced solid tumors including kidney cancer, lung cancer, ...
| |||||
Rob Stone, Master Marketer of Hip-Hop, Is Dead at 55 - The New York Times He was 55. His longtime professional partner, Jon Cohen, said the cause of his death, in a hospital, was lung cancer. Early in his music business ...
| |||||
Roche to halt lung cancer trial - Halifax – Market news Roche is to end a novel lung cancer treatment trial, the Swiss company confirmed on Thursday, following "disappointing" results. Roche Holding Ag; 04 ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment